National Repository of Grey Literature 2 records found  Search took 0.00 seconds. 
Analysis of health care system
Jandejsková, Klára ; Ježek, Tomáš (advisor) ; Durdisová, Jaroslava (referee)
This master's thesis is focused on the comparison of different systems of payment for health care in the Czech Republic. Insurance companies play an essential part in financing health care and they are also responsible for setting the rules for health care providers, who in turn modify the systems of financing health care that had been set out. This is the reason why the issues concerning insurance companies are discussed in both parts of this thesis, firstly the theoretical side and secondly the practical one. The theoretical part of this thesis discusses the structure of the czech healthcare system as a whole and then the payment systems set up for individual providers of health care are analysed in the following chapters. The practical part shows examples of how the payment system for health care works, what problems it encounters, what exactly is the role of insurance companies and how to deal with presented problems. The aim of this thesis is to provide an overview of the types of payment systems for health care used in the Czech Republic and further focus on the specifics and details that are analysed along with their potential impact on the amount of the final payment.
Generic vs. original drugs or how compete each other on the Czech market
Jandejsková, Klára ; Janíčko, Martin (advisor) ; Špecián, Petr (referee)
The main aim of this bachelor thesis is to clarify mutual competition between original and generics drugs on drugs markets. It is necessary to identify all aspects which we can meet on drug market and which play a significant role in the competition. The description of these aspects is described in the theoretical part of this assignment which is (together with graphic model of original and generics competition) the main theoretical basis for the practical part. In the practical part the analysis of competition process is carried out by descriptive analysis. The analysis is especially aimed at changes in quantity and prices of the original drug and gives answers to why these changes happened. The conclusion is devoted to spending on research and development of new drug. By means of practical example and also of all information which are mentioned in this work, this part answers the question which measurements of drug and state policy are suitable or unsuitable for research and development of new drugs.

See also: similar author names
2 JANDEJSKOVÁ, Karolína
2 Jandejsková, Karolína
Interested in being notified about new results for this query?
Subscribe to the RSS feed.